Your browser doesn't support javascript.
Enhanced national surveillance of severe acute respiratory infections (SARI) within COVID-19 surveillance, Slovenia, weeks 13 to 37 2021.
Klavs, Irena; Serdt, Mojca; Ucakar, Veronika; Grgic-Vitek, Marta; Fafangel, Mario; Mrzel, Maja; Berlot, Lina; Glavan, Uros; Vrh, Marjana; Kustec, Tanja; Simoniti, Miha; Kotnik Kevorkijan, Bozena; Lejko Zupanc, Tatjana.
  • Klavs I; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Serdt M; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Ucakar V; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Grgic-Vitek M; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Fafangel M; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Mrzel M; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Berlot L; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Glavan U; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Vrh M; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Kustec T; Communicable Diseases Centre, National Institute of Public Health, Ljubljana, Slovenia.
  • Simoniti M; Department of Infectious Diseases and Febrile Conditions, General Hospital Celje, Celje, Slovenia.
  • Kotnik Kevorkijan B; Department for Infectious Diseases and Febrile Conditions, University Medical Centre Maribor, Maribor, Slovenia.
  • Lejko Zupanc T; Department for Infectious Diseases and Febrile Conditions, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Euro Surveill ; 26(42)2021 10.
Article in English | MEDLINE | ID: covidwho-1485003
ABSTRACT
We monitored trends of severe COVID-19 morbidity in Slovenia during weeks 13 to 37 2021. National weekly rates of severe acute respiratory infections (SARI) cases testing positive for SARS-CoV-2 at admission in all hospitals varied between 0.2 and 16.3 cases per 100,000 population. Of those without previous COVID-19 diagnosis, SARI COVID-19 admission rates ranged between 0.3 and 17.5 per 100,000 unvaccinated, and 0.0 and 7.3 per 100,000 fully vaccinated individuals. National SARI COVID-19 surveillance is essential in informing COVID-19 response.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Tract Infections / Influenza, Human / COVID-19 Type of study: Diagnostic study / Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: 1560-7917.ES.2021.26.42.2100937

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Tract Infections / Influenza, Human / COVID-19 Type of study: Diagnostic study / Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: 1560-7917.ES.2021.26.42.2100937